Market Overview:
The global rabies antiserum market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of rabies, increasing awareness about rabies and its prevention, and technological advancements in the field of rabies diagnosis and treatment. Based on type, the global rabies antiserum market is segmented into 1500IU, 1000IU, 400IU, and other types. The 1000IU segment is expected to account for the largest share of the global Rabais Antiserum Market in 2018. This can be attributed to factors such as rising demand for monoclonal antibodies (mAbs) for prophylaxis against various diseases including rabies and growing investments by key players in this segment. Based on application, the global Rabais Antiserum Market is divided into category II exposure and category III exposure segments.
Product Definition:
Rabies Antiserum is a serum that is used to treat rabies. Rabies is a serious disease that can be fatal, and the antiserum can help to prevent or treat the infection.
1500IU:
1500IU is a unit used to measure the amount of immunoglobulin in a given volume. The 1500IU definition comes from the fact that it is approximately equal to 1/4th of a regular IPU.
1000IU:
1000IU is a unit used for measuring the amount of immunoglobulin in serums or plasma. It is also called as International Units (IUs) or mili-international units. 1000IU is equal to 1/100th of a U.S. fluid ounce, approximately 0.3 ml, or 4 drops; there are 100 drops in one US fluid ounce and there are 4 such ounces in a liter; therefore, 1000 IUs equal 1 litre (L).
Application Insights:
The category II exposure application segment led the global market in 2017. The major factor contributing to its dominance is that this is the most commonly reported type of rabies infection. According to WHO, approximately 70% of all reported cases occur through contact with infected animals or animal products like meat and bone meal. Therefore, a large number of people get exposed to rabies through casual contact with animals or by getting bitten by rabid dogs.
Category III exposure is expected to be the fastest-growing segment over the forecast period owing to increased awareness about prevention against rabid dog bites among travelers and military personnel as well as healthcare professionals working in countries whererabies has been endemic for a long time such as India and China.
Regional Analysis:
North America dominated the global market in 2017. The presence of a well-developed healthcare infrastructure and high awareness levels coupled with effective animal control measures are some of the major factors responsible for its large share. Moreover, according to WHO, 95% of human deaths attributed to rabies occur in Asia & Africa countries which indicates that most people get vaccinated against this disease in developed regions such as North America and Europe.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to rising incidence rates of dog bites and other category II exposures especially in developing economies such as India, China, Indonesia among others. Furthermore, increasing number of animalbite related deaths have resulted into an increase demand for antiserum thus driving regional market growth over the forecast period.
Growth Factors:
- Increasing incidence of rabies across the globe
- Growing awareness about the disease and its prevention methods
- Rising demand for effective and affordable rabies treatment options
- Technological advancements in rabies vaccine development and production processes
- Growing number of public-private sector collaborations to support rabies control initiatives
Scope Of The Report
Report Attributes
Report Details
Report Title
Rabies Antiserum Market Research Report
By Type
1500IU, 1000IU, 400IU, Other
By Application
Category II Exposure, Category III Exposure
By Companies
Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical, Bharat Serums
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Rabies Antiserum Market Report Segments:
The global Rabies Antiserum market is segmented on the basis of:
Types
1500IU, 1000IU, 400IU, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Category II Exposure, Category III Exposure
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Serum China
- Lanzhou Institute of Biological Products
- Wuhan Institute of Biological Products
- Premium Serums
- Haffkine Bio-Pharmaceutical
- Bharat Serums
Highlights of The Rabies Antiserum Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 1500IU
- 1000IU
- 400IU
- Other
- By Application:
- Category II Exposure
- Category III Exposure
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rabies Antiserum Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rabies Antiserum is a serum that neutralizes the rabies virus. It is given to people who may have been exposed to the rabies virus, such as healthcare workers and patients who have been bitten or scratched by an animal with rabies.
Some of the major companies in the rabies antiserum market are Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical, Bharat Serums.
The rabies antiserum market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rabies Antiserum Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rabies Antiserum Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rabies Antiserum Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rabies Antiserum Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rabies Antiserum Market Size & Forecast, 2020-2028
4.5.1 Rabies Antiserum Market Size and Y-o-Y Growth
4.5.2 Rabies Antiserum Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 1500IU
5.2.2 1000IU
5.2.3 400IU
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Category II Exposure
6.2.2 Category III Exposure
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rabies Antiserum Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rabies Antiserum Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 1500IU
9.6.2 1000IU
9.6.3 400IU
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Category II Exposure
9.10.2 Category III Exposure
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 1500IU
10.6.2 1000IU
10.6.3 400IU
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Category II Exposure
10.10.2 Category III Exposure
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 1500IU
11.6.2 1000IU
11.6.3 400IU
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Category II Exposure
11.10.2 Category III Exposure
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 1500IU
12.6.2 1000IU
12.6.3 400IU
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Category II Exposure
12.10.2 Category III Exposure
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 1500IU
13.6.2 1000IU
13.6.3 400IU
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Category II Exposure
13.10.2 Category III Exposure
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rabies Antiserum Market: Competitive Dashboard
14.2 Global Rabies Antiserum Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Serum China
14.3.2 Lanzhou Institute of Biological Products
14.3.3 Wuhan Institute of Biological Products
14.3.4 Premium Serums
14.3.5 Haffkine Bio-Pharmaceutical
14.3.6 Bharat Serums
